CN115887561A - Eye ointment with function of treating eye diseases and production process thereof - Google Patents

Eye ointment with function of treating eye diseases and production process thereof Download PDF

Info

Publication number
CN115887561A
CN115887561A CN202310168928.XA CN202310168928A CN115887561A CN 115887561 A CN115887561 A CN 115887561A CN 202310168928 A CN202310168928 A CN 202310168928A CN 115887561 A CN115887561 A CN 115887561A
Authority
CN
China
Prior art keywords
portions
parts
oil
eye
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310168928.XA
Other languages
Chinese (zh)
Inventor
许梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202310168928.XA priority Critical patent/CN115887561A/en
Publication of CN115887561A publication Critical patent/CN115887561A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses an eye ointment with a function of treating eye diseases, which specifically comprises the following components: groundsel, pearl, phellodendron, saffron, honeysuckle, cassia seed, pale butterflybush flower, bat dung, pipewort, silkworm excrement, cicada slough, abalone shell, forsythia, coptis, chrysanthemum, mulberry leaf, lithospermum, red ginseng, liquorice, musk extract, menthol, borneol, ostrich oil, snake oil and silk oil, and also discloses a production process of the eye ointment with the function of treating eye diseases. The invention relates to the technical field of eye ointments, and particularly provides an eye ointment which is safe and healthy and can effectively treat various eye diseases and has a function of treating eye diseases, and a production process thereof.

Description

Eye ointment with function of treating eye diseases and production process thereof
Technical Field
The invention relates to the technical field of eye ointments, in particular to an eye ointment with a function of treating eye diseases and a production process thereof.
Background
The eyes are 'soul' windows, each person has a distinctive pair of eyes, and each person should take care of their own eyes. However, with the popularization of electronic products in recent years, more and more people have dry eyes, uncomfortable eyes and eye fatigue due to long-term use of electronic products, and more people suffer from eye diseases such as myopia, hyperopia and strabismus. The conventional eye ointment generally has the effects of relieving dry eyes, dry eyes and asthenopia, but does not have the efficacy of treating eye diseases.
Disclosure of Invention
In order to overcome the defects, the invention provides the eye ointment which is safe and healthy, can effectively treat various eye diseases and has the function of treating the eye diseases and the production process thereof.
The invention provides the following technical scheme: the invention provides an eye ointment with a function of treating eye diseases, which comprises the following components in parts by weight: 10 to 30 portions of groundsel, 7 to 13 portions of pearl, 7 to 13 portions of phellodendron, 11 to 19 portions of saffron, 11 to 19 portions of honeysuckle, 10 to 30 portions of cassia seed, 7 to 13 portions of butterflybush flower, 7 to 13 portions of bat dung, 11 to 19 portions of pipewort, 11 to 19 portions of silkworm excrement, 7 to 13 portions of cicada slough, 11 to 19 portions of abalone shell, 11 to 19 portions of weeping forsythia, 3 to 7 portions of coptis, 10 to 30 portions of chrysanthemum, 10 to 30 portions of mulberry leaf, 7 to 13 portions of lithospermum, 7 to 13 portions of red ginseng, 7 to 13 portions of liquorice, 1 to 3 portions of musk extract, 3 to 7 portions of menthol, 1 to 5 portions of borneol, 0.5 to 1.5 portions of ostrich oil, 0.5 to 1.5 portions of snake oil and 0.5 to 1.5 portions of silkworm oil.
Preferably, the eye ointment with the function of treating eye diseases comprises the following components in parts by weight: 15 to 25 portions of groundsel, 9 to 11 portions of pearl, 9 to 11 portions of phellodendron, 14 to 16 portions of saffron, 14 to 16 portions of honeysuckle, 15 to 25 portions of cassia seed, 9 to 11 portions of butterflybush flower, 9 to 11 portions of bat dung, 14 to 16 portions of pipewort, 14 to 16 portions of silkworm excrement, 9 to 11 portions of cicada slough, 14 to 16 portions of abalone shell, 14 to 16 portions of weeping forsythia, 4 to 6 portions of coptis, 15 to 25 portions of chrysanthemum, 15 to 25 portions of mulberry leaf, 9 to 11 portions of lithospermum, 9 to 11 portions of red ginseng, 9 to 11 portions of liquorice, 1.5 to 2.5 portions of musk extract, 4 to 6 portions of menthol, 2 to 4 portions of borneol, 0.8 to 1.2 portions of ostrich oil, 0.8 to 1.2 portions of snake oil and 0.8 to 1.2 portions of silkworm oil.
Preferably, the eye ointment with the function of treating eye diseases comprises the following components in parts by weight: 20 parts of groundsel, 10 parts of pearl, 10 parts of phellodendron, 15 parts of saffron, 15 parts of honeysuckle, 20 parts of cassia seed, 10 parts of butterflybush flower, 10 parts of bat dung, 15 parts of pipewort, 15 parts of silkworm excrement, 10 parts of cicada slough, 15 parts of abalone shell, 15 parts of forsythia, 5 parts of coptis chinensis, 20 parts of chrysanthemum, 20 parts of mulberry leaf, 10 parts of lithospermum, 10 parts of red ginseng, 10 parts of liquorice, 2 parts of musk extract, 5 parts of menthol, 3 parts of borneol, 1 part of ostrich oil, 1 part of snake oil and 1 part of silkworm oil.
A production process of an eye ointment with the function of treating eye diseases specifically comprises the following steps:
(1) Weighing the traditional Chinese medicine components according to the corresponding weight proportion, crushing, grinding, sieving with a 20-35 mesh sieve, and uniformly mixing;
(2) Uniformly mixing the traditional Chinese medicine mixed powder with deionized water, and soaking for 0.5-3 h to obtain a soaking solution;
(3) Decocting: decocting the soak solution for 0.5 to 1 hour, filtering the soak solution for later use, adding deionized water into filter residues, decocting the filter residues for 1 to 1.5 hours, filtering the filter residues, and combining the two filtrates;
(4) Preparing paste: and uniformly mixing the two filtrates with the ostrich oil, the snake oil and the silk oil in corresponding weight proportions to obtain the eye ointment.
Preferably, the mixing ratio of the traditional Chinese medicine mixed powder in the step (2) to the deionized water is 1: (3-5).
Preferably, the mixing ratio of the filter residue and the deionized water in the step (3) is 1: (2-3).
The invention adopting the structure has the following beneficial effects: the invention provides an eye ointment and its preparation method with function of treating eye disease, through more than 20 Chinese medicines are cooperated with ostrich oil, snake oil and silk oil, on the basis of relieving dry eye, eye puckery and eye fatigue, have good quality function to treat myopia, hypermetropia and strabismus too; the butterflybush flower in the traditional Chinese medicine component formula has the effects of clearing heat, improving eyesight and reducing intraocular pressure; the bat dung has the effects of dissipating blood stasis and improving eyesight; flos Eriocauli has effects of clearing heat and improving eyesight; silkworm excrement and cicada slough are used together to have the effects of dispelling wind and dredging collaterals; the combination of fructus forsythiae and Coptidis rhizoma has effects of clearing away heat and toxic materials and dispelling wind and heat.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example one
An eye ointment with the function of treating eye diseases comprises the following components in parts by weight: 20 parts of groundsel, 10 parts of pearl, 10 parts of phellodendron, 15 parts of saffron, 15 parts of honeysuckle, 20 parts of cassia seed, 10 parts of butterflybush flower, 10 parts of bat dung, 15 parts of pipewort, 15 parts of silkworm excrement, 10 parts of cicada slough, 15 parts of abalone shell, 15 parts of forsythia, 5 parts of coptis chinensis, 20 parts of chrysanthemum, 20 parts of mulberry leaf, 10 parts of lithospermum, 10 parts of red ginseng, 10 parts of liquorice, 2 parts of musk extract, 5 parts of menthol, 3 parts of borneol, 1 part of ostrich oil, 1 part of snake oil and 1 part of silkworm oil.
A production process of an eye ointment with the function of treating eye diseases specifically comprises the following steps:
(1) Weighing the traditional Chinese medicine components according to the corresponding weight proportion, crushing, grinding, sieving with a 20-35 mesh sieve, and uniformly mixing;
(2) Mixing the traditional Chinese medicine mixed powder with deionized water in a proportion of 1:4, uniformly mixing the components in proportion, and soaking for 2 hours to obtain a soaking solution;
(3) Decocting: decocting the soaking solution for 0.5h, filtering, reserving the filtrate for later use, adding deionized water into filter residues, decocting for 1h, wherein the mixing ratio of the filter residues to the deionized water is 1:2.5, filtering and then combining the two filtrates;
(4) Preparing paste: and uniformly mixing the two filtrates with the ostrich oil, the snake oil and the silk oil in corresponding weight proportions to obtain the eye ointment.
Example two
An eye ointment with the function of treating eye diseases comprises the following components in parts by weight: 10 parts of groundsel, 7 parts of pearl, 7 parts of phellodendron, 11 parts of saffron, 11 parts of honeysuckle, 10 parts of cassia seed, 7 parts of butterflybush flower, 7 parts of bat dung, 11 parts of pipewort, 11 parts of silkworm excrement, 7 parts of cicada slough, 11 parts of abalone shell, 11 parts of fructus forsythiae, 3 parts of coptis chinensis, 10 parts of chrysanthemum, 10 parts of mulberry leaf, 7 parts of lithospermum, 7 parts of red ginseng, 7 parts of liquorice, 1 part of musk extract, 3 parts of menthol, 1 part of borneol, 0.5 part of ostrich oil, 0.5 part of snake oil and 0.5 part of silk oil.
A production process of an eye ointment with the function of treating eye diseases specifically comprises the following steps:
(1) Weighing the traditional Chinese medicine components according to the corresponding weight proportion, crushing, grinding, sieving by a sieve of 20-35 meshes, and uniformly mixing;
(2) Mixing the traditional Chinese medicine mixed powder with deionized water in a proportion of 1:3, uniformly mixing the components, and soaking for 0.5h to obtain a soaking solution;
(3) Decocting: decocting the soaking solution for 0.5h, filtering, reserving the filtrate for later use, adding deionized water into filter residues, decocting for 1h, wherein the mixing ratio of the filter residues to the deionized water is 1:2, filtering and then combining the two filtrates;
(4) Preparing paste: and mixing the two filtrates with ostrich oil, snake oil and silk oil in corresponding weight proportion uniformly to obtain the eye ointment.
EXAMPLE III
An eye ointment with the function of treating eye diseases comprises the following components in parts by weight: 30 parts of groundsel, 13 parts of pearl, 13 parts of phellodendron, 19 parts of saffron, 19 parts of honeysuckle, 30 parts of cassia seed, 13 parts of butterflybush flower, 13 parts of bat dung, 19 parts of pipewort, 19 parts of silkworm excrement, 13 parts of cicada slough, 19 parts of abalone shell, 19 parts of fructus forsythiae, 7 parts of coptis chinensis, 30 parts of chrysanthemum, 30 parts of mulberry leaf, 13 parts of lithospermum, 13 parts of red ginseng, 13 parts of liquorice, 3 parts of musk extract, 7 parts of menthol, 5 parts of borneol, 1.5 parts of ostrich oil, 1.5 parts of snake oil and 1.5 parts of silk oil.
A production process of an eye ointment with the function of treating eye diseases specifically comprises the following steps:
(1) Weighing the traditional Chinese medicine components according to the corresponding weight proportion, crushing, grinding, sieving by a sieve of 20-35 meshes, and uniformly mixing;
(2) Mixing the traditional Chinese medicine mixed powder with deionized water in a proportion of 1:5, uniformly mixing the components in proportion, and soaking for 3 hours to obtain a soaking solution;
(3) Decocting: decocting the soaking solution for 1h, filtering, and reserving the filtrate for later use, adding deionized water into the filter residue, and decocting for 1.5h, wherein the mixing ratio of the filter residue to the deionized water is 1:3, filtering and combining the two filtrates;
(4) Preparing paste: and uniformly mixing the two filtrates with the ostrich oil, the snake oil and the silk oil in corresponding weight proportions to obtain the eye ointment.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Furthermore, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (6)

1. The eye ointment with the function of treating eye diseases is characterized by comprising the following components in parts by weight: 10 to 30 portions of groundsel, 7 to 13 portions of pearl, 7 to 13 portions of phellodendron, 11 to 19 portions of saffron, 11 to 19 portions of honeysuckle, 10 to 30 portions of cassia seed, 7 to 13 portions of butterflybush flower, 7 to 13 portions of bat dung, 11 to 19 portions of pipewort, 11 to 19 portions of silkworm excrement, 7 to 13 portions of cicada slough, 11 to 19 portions of abalone shell, 11 to 19 portions of weeping forsythia, 3 to 7 portions of coptis, 10 to 30 portions of chrysanthemum, 10 to 30 portions of mulberry leaf, 7 to 13 portions of lithospermum, 7 to 13 portions of red ginseng, 7 to 13 portions of liquorice, 1 to 3 portions of musk extract, 3 to 7 portions of menthol, 1 to 5 portions of borneol, 0.5 to 1.5 portions of ostrich oil, 0.5 to 1.5 portions of snake oil and 0.5 to 1.5 portions of silkworm oil.
2. The eye ointment with the function of treating eye diseases as claimed in claim 1, which is characterized by comprising the following components in parts by weight: 15 to 25 portions of groundsel, 9 to 11 portions of pearl, 9 to 11 portions of phellodendron bark, 14 to 16 portions of saffron, 14 to 16 portions of honeysuckle, 15 to 25 portions of cassia seed, 9 to 11 portions of butterflybush flower, 9 to 11 portions of bat dung, 14 to 16 portions of pipewort, 14 to 16 portions of silkworm excrement, 9 to 11 portions of cicada slough, 14 to 16 portions of abalone shell, 14 to 16 portions of weeping forsythia, 4 to 6 portions of coptis root, 15 to 25 portions of chrysanthemum, 15 to 25 portions of mulberry leaf, 9 to 11 portions of lithospermum, 9 to 11 portions of red ginseng, 9 to 11 portions of liquorice, 1.5 to 2.5 portions of musk extract, 4 to 6 portions of menthol, 2 to 4 portions of borneol, 0.8 to 1.2 portions of ostrich oil, 0.8 to 1.2 portions of snake oil and 0.8 to 1.2 portions of silkworm oil.
3. The eye ointment with the function of treating eye diseases as claimed in claim 1, which is characterized by comprising the following components in parts by weight: 20 parts of groundsel, 10 parts of pearl, 10 parts of phellodendron, 15 parts of saffron, 15 parts of honeysuckle, 20 parts of cassia seed, 10 parts of butterflybush flower, 10 parts of bat dung, 15 parts of pipewort, 15 parts of silkworm excrement, 10 parts of cicada slough, 15 parts of abalone shell, 15 parts of forsythia, 5 parts of coptis chinensis, 20 parts of chrysanthemum, 20 parts of mulberry leaf, 10 parts of lithospermum, 10 parts of red ginseng, 10 parts of liquorice, 2 parts of musk extract, 5 parts of menthol, 3 parts of borneol, 1 part of ostrich oil, 1 part of snake oil and 1 part of silkworm oil.
4. A process for producing an eye ointment having an eye disease treatment function according to any one of claims 1 to 3, which comprises the following steps:
(1) Weighing the traditional Chinese medicine components according to the corresponding weight proportion, crushing, grinding, sieving with a 20-35 mesh sieve, and uniformly mixing;
(2) Uniformly mixing the traditional Chinese medicine mixed powder with deionized water, and soaking for 0.5-3 h to obtain a soaking solution;
(3) Decocting: decocting the soaking solution for 0.5-1 h, filtering, reserving the filtrate for later use, adding deionized water into the filter residue, decocting for 1-1.5 h, filtering, and combining the two filtrates;
(4) Preparing paste: and uniformly mixing the two filtrates with the ostrich oil, the snake oil and the silk oil in corresponding weight proportions to obtain the eye ointment.
5. The process for producing eye ointment for eye diseases as claimed in claim 4, wherein the mixing ratio of the mixed powder of Chinese herbs and deionized water in step (2) is 1: (3-5).
6. The process for producing an eye ointment having the function of treating eye diseases according to claim 4, wherein the mixing ratio of the filter residue and the deionized water in the step (3) is 1: (2-3).
CN202310168928.XA 2023-02-27 2023-02-27 Eye ointment with function of treating eye diseases and production process thereof Pending CN115887561A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310168928.XA CN115887561A (en) 2023-02-27 2023-02-27 Eye ointment with function of treating eye diseases and production process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310168928.XA CN115887561A (en) 2023-02-27 2023-02-27 Eye ointment with function of treating eye diseases and production process thereof

Publications (1)

Publication Number Publication Date
CN115887561A true CN115887561A (en) 2023-04-04

Family

ID=86488417

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310168928.XA Pending CN115887561A (en) 2023-02-27 2023-02-27 Eye ointment with function of treating eye diseases and production process thereof

Country Status (1)

Country Link
CN (1) CN115887561A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106421695A (en) * 2016-10-14 2017-02-22 周南燕 Traditional Chinese medicine composition for eye care
CN110151975A (en) * 2019-06-03 2019-08-23 贵阳思穆云品电子商务有限公司 A kind of anti-radiation blue light improves the clear and rich liquid and preparation method thereof of eyesight
CN115645454A (en) * 2022-09-29 2023-01-31 惠眸易效(黄骅)科技有限公司 External cream for treating myopia and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106421695A (en) * 2016-10-14 2017-02-22 周南燕 Traditional Chinese medicine composition for eye care
CN110151975A (en) * 2019-06-03 2019-08-23 贵阳思穆云品电子商务有限公司 A kind of anti-radiation blue light improves the clear and rich liquid and preparation method thereof of eyesight
CN115645454A (en) * 2022-09-29 2023-01-31 惠眸易效(黄骅)科技有限公司 External cream for treating myopia and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
孙玉信: "张磊应用谷青汤的经验", 辽宁中医杂志, no. 03, pages 138 - 139 *

Similar Documents

Publication Publication Date Title
CN104173635A (en) Drug for treating acnes and preparation method of drug
CN103549590A (en) Preparation method for blueberry and black fungus mixed juice beverage
CN106336940A (en) Preparation method of rapeseed oil for enriching blood and tonifying qi
CN103690655A (en) External medicine for treating infantile eczema
CN115887561A (en) Eye ointment with function of treating eye diseases and production process thereof
CN103652173A (en) Health-care tea containing shaddock peels and turmeric and preparation method of health-care tea
CN113144102A (en) Novel eye drop for improving eyesight and resisting fatigue
CN112294900A (en) Eye-protecting liquid and preparation method thereof
CN110840783A (en) Herbal technology scalp washing and caring liquid and preparation method thereof
CN111821359A (en) Method for preparing compound ointment for nursing and repairing wet skin ulceration for radiotherapy department
CN101181528A (en) Compound giant knotweed burn film coating agent and preparation method thereof
CN1132595C (en) Eye disease preventing oral liquid and its preparation
CN103142718B (en) Liquid medicine for treating freezing injury
CN110857412A (en) Preparation method of tableware detergent
CN105663946A (en) Traditional Chinese medicine for treating dry eyes and preparing method of traditional Chinese medicine
CN1081898A (en) Oil as ophthalmic medicine
CN105056185A (en) Traditional Chinese medicine for treating rhinitis
CN115590169A (en) Mulberry paste and preparation method thereof
CN105796796A (en) External plaster for promoting blood circulation to remove blood stasis and manufacturing method thereof
CN110269104A (en) A kind of culinary art sesame oil and its preparation process
CN109078085A (en) A kind of preparation method of pharmaceutical hydrogel that treating the dry and astringent inflammation of asthenopia
CN112106839A (en) Plant beverage for conditioning and treating lung diseases and preparation method thereof
CN114558073A (en) Essential oil with dehumidifying function
CN104706565A (en) Scrap-removing and alopecia-preventing liquid shampoo and preparation method thereof
CN116173113A (en) Medicament for treating burns and scalds and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination